News
-
-
-
PRESS RELEASE
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Bausch Health Companies Inc., Salix Pharmaceuticals, and healthcare organizations join forces for the second annual Opioid-Induced Constipation Awareness Day to raise awareness and support patients affected by OIC -
-
-
-
-
-
PRESS RELEASE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Bausch Health, Canada announces positive reimbursement recommendations for new acne treatment CABTREO, the first triple-combination topical therapy approved in Canada -
PRESS RELEASE
(Pr)CABTREO(MC) (phosphate de clindamycine, adapalène et gel de peroxyde de benzoyle), un traitement pour l'acné vulgaire, reçoit des recommandations de remboursement de l'Agence des médicaments du Canada et de l'INESSS, au Québec
Bausch Health, Canada Inc., une filiale de Bausch Health Companies Inc., annonce des recommandations positives de remboursement de CABTREO, un nouveau traitement topique triple pour l'acné vulgaire, par l'AMC et l'INESSS
